JINHAI MED TECH (02225) Set to Join Hang Seng Composite Index, Poised for Stock Connect Inclusion

Stock News08-21

On August 21, Hang Seng Indexes Company unveiled the results of its quarterly index review for the period ending June 30, 2026, with JINHAI MED TECH (02225) being added to the Hang Seng Composite Index. The adjustment to the index will take effect after the market close on Friday, September 4, and will become active starting Monday, September 7, prompting the Shanghai and Shenzhen stock exchanges to correspondingly update the eligible list of securities for the Stock Connect program.

The inclusion positions JINHAI MED TECH as a strong candidate for the Southbound Trading channel, given that it satisfies a range of criteria, including thresholds for market capitalization and liquidity. On August 3, the company issued an announcement confirming the appointment of Mr. Ma Chengdong as its Group Chief Marketing Officer, effective from August 3, 2026, with an initial term of one year.

In his new role, Mr. Ma is tasked with overseeing the group's marketing strategy, market access initiatives, academic promotion, and sales and channel operations, in addition to supervising the commercialization efforts of its medical devices and equipment portfolio.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1190983918?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-21 19:02","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1190983918","market":"fut","top_or_hot":-1,"title":"JINHAI MED TECH (02225) Set to Join Hang Seng Composite Index, Poised for Stock Connect Inclusion","media":"Stock News","content":"<p>On August 21, Hang Seng Indexes Company unveiled the results of its quarterly index review for the period ending June 30, 2026, with <b>JINHAI MED TECH</b> (02225) being added to the Hang Seng Composite Index. The adjustment to the index will take effect after the market close on Friday, September 4, and will become active starting Monday, September 7, prompting the Shanghai and Shenzhen stock exchanges to correspondingly update the eligible list of securities for the Stock Connect program. <br><br>\nThe inclusion positions <b>JINHAI MED TECH</b> as a strong candidate for the Southbound Trading channel, given that it satisfies a range of criteria, including thresholds for market capitalization and liquidity. On August 3, the company issued an announcement confirming the appointment of Mr. Ma Chengdong as its Group Chief Marketing Officer, effective from August 3, 2026, with an initial term of one year. <br><br>\nIn his new role, Mr. Ma is tasked with overseeing the group's marketing strategy, market access initiatives, academic promotion, and sales and channel operations, in addition to supervising the commercialization efforts of its medical devices and equipment portfolio.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>JINHAI MED TECH (02225) Set to Join Hang Seng Composite Index, Poised for Stock Connect Inclusion</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nJINHAI MED TECH (02225) Set to Join Hang Seng Composite Index, Poised for Stock Connect Inclusion\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-08-21 19:02</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>On August 21, Hang Seng Indexes Company unveiled the results of its quarterly index review for the period ending June 30, 2026, with <b>JINHAI MED TECH</b> (02225) being added to the Hang Seng Composite Index. The adjustment to the index will take effect after the market close on Friday, September 4, and will become active starting Monday, September 7, prompting the Shanghai and Shenzhen stock exchanges to correspondingly update the eligible list of securities for the Stock Connect program. <br><br>\nThe inclusion positions <b>JINHAI MED TECH</b> as a strong candidate for the Southbound Trading channel, given that it satisfies a range of criteria, including thresholds for market capitalization and liquidity. On August 3, the company issued an announcement confirming the appointment of Mr. Ma Chengdong as its Group Chief Marketing Officer, effective from August 3, 2026, with an initial term of one year. <br><br>\nIn his new role, Mr. Ma is tasked with overseeing the group's marketing strategy, market access initiatives, academic promotion, and sales and channel operations, in addition to supervising the commercialization efforts of its medical devices and equipment portfolio.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02225","symbol_name":"今海医疗科技","start_time":0,"source_url":"","article_id":"1190983918","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1190983918","pubTimestamp":1787310143,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"On August 21, Hang Seng Indexes Company unveiled the results of its quarterly index review for the period ending June 30, 2026, with JINHAI MED TECH (02225) being added to the Hang Seng Composite...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02225":"今海医疗科技","HSCI":"恒生综合指数","FLHK":"Franklin FTSE Hong Kong ETF","BK1150":"人力资源与就业服务"},"translate_title":"金海医疗科技(02225)将加入恒生综合指数，准备纳入股票通","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"FLHK":1,"02225":1,"HSCI":1},"content_text":"On August 21, Hang Seng Indexes Company unveiled the results of its quarterly index review for the period ending June 30, 2026, with JINHAI MED TECH (02225) being added to the Hang Seng Composite Index. The adjustment to the index will take effect after the market close on Friday, September 4, and will become active starting Monday, September 7, prompting the Shanghai and Shenzhen stock exchanges to correspondingly update the eligible list of securities for the Stock Connect program. \nThe inclusion positions JINHAI MED TECH as a strong candidate for the Southbound Trading channel, given that it satisfies a range of criteria, including thresholds for market capitalization and liquidity. On August 3, the company issued an announcement confirming the appointment of Mr. Ma Chengdong as its Group Chief Marketing Officer, effective from August 3, 2026, with an initial term of one year. \nIn his new role, Mr. Ma is tasked with overseeing the group's marketing strategy, market access initiatives, academic promotion, and sales and channel operations, in addition to supervising the commercialization efforts of its medical devices and equipment portfolio.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.49.0","shortVersion":"4.49.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1190983918","isCrawlerRequest":true}